Statistics
Publications
4
Citations
544
H-Index
4
Active since
2009
Affiliations
AbbVie (United States)(Current)
Kelly L. Klinge is an author at AbbVie (United States) specializing in medicine, molecular biology, and cell signaling.
Publications per year
2009–2023
4
4
The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity
Christina K. Baumgartner, Hakimeh Ebrahimi-Nik, Arvin Iracheta‐Vellve et al. · Nature · 2023 · 145 citations · Full text
1–4 of 4